SCHEDULE 13G/A 0001137439-25-000228 0002044285 XXXXXXXX LIVE 3 Common 12/31/2025 0001849296 OKYO Pharma Ltd G6724L116 Floor 4, 14/15 Conduit St LONDON X0 W1S 2XJ Rule 13d-1(c) Dauntless Investment Group, LLC DE 0.00 0.00 360352.00 111171.00 471523.00 1.2 OO Single Family Office/Passive Investor OKYO Pharma Ltd Floor 4, 14/15 Conduit St, LONDON, UNITED KINGDOM, W1S 2XJ. Dauntless Investment Group, LLC 3283 Foxfire Dr., Milford, MI 48380 Delaware Y 471,523 1.17% 0 0 360,352 111,171 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Dauntless Investment Group, LLC /s/Matthew Okkerse 02/12/2026